Picture of Filtronic logo

FTC Filtronic News Story

0.000.00%
gb flag iconLast trade - 00:00
TechnologyHighly SpeculativeMid CapHigh Flyer

REG - Filtronic PLC - Interim Results

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260203:nRSC4033Ra&default-theme=true

RNS Number : 4033R  Filtronic PLC  03 February 2026

3 February 2026

 

 

FILTRONIC PLC

("Filtronic", the "Company" or the "Group")

 

HALF YEAR RESULTS FOR THE SIX MONTHS ENDED 30 NOVEMBER 2025

 

Filtronic plc (AIM: FTC), the designer and manufacturer of products and
sub-systems for the aerospace, defence, telecoms infrastructure, space and
critical communications markets, is pleased to announce its half year results
for the six months ended 30 November 2025 ("H1 2026").

 

The Group delivered an encouraging first-half performance, with financial
results in line with the Board's expectations and very positive momentum in
new business activity. Revenue was similar to the record prior period which
benefited from peak delivery on major space programmes. H1 2026 displayed a
more balanced delivery profile with profitability reflecting deliberate and
targeted investment in people, facilities and product development to position
the business for accelerated growth. Cash generation remained strong, enabling
continued strategic investment and leaving the Group well positioned to
capitalise on a rapidly expanding Defence and Space pipeline. Following strong
order levels in H1 2026, Filtronic has entered the second half of FY2026 with
a record order book, providing clear visibility and confidence in our strategy
and sustained long- term growth.

 

Financial
Highlights

                                                       H1 2026         H1 2025
 Revenue                                               £25.3m          £25.6m
 Adjusted EBITDA¹                                      £5.1m           £8.7m
 Operating profit                                      £2.6m           £6.8m
 Profit for the period                                 £2.6m           £6.7m
 Basic earnings per share                              1.20p           3.08p
 Diluted earnings per share                            1.14p           3.04p
 Cash generated from operating activities              £3.4m           £2.1m

                                                       At 30 Nov 2025  At 30 Nov 2024

 Net cash when including right of use property leases  £6.8m           £4.3m
 Net cash when excluding right of use property leases  £8.2m           £5.1m

¹ Adjusted EBITDA is earnings before interest, taxation, depreciation,
amortisation, share-based payments and exceptional items.

 

Significant contract momentum and diversification of revenue mix

 

 ·             Continued deepening of the relationships with key customers, including
               largest-ever contract with SpaceX, valued at $62.5 million.
 ·             Accelerating diversification of customer base, with new multi-year contract
               wins including a €7.0 million agreement with a European space customer and a
               £13.4 million contract with a leading European defence prime, strengthening
               the Company's position across space, aerospace and defence markets.

 

Continued execution of five-year growth strategy

 

 ·             Deployment of GaN E-band products represents a step change in performance,
               unlocking emerging opportunities in space ground systems and high-capacity
               data links.
 ·             Broadening of addressable markets, with development underway on additional
               frequency bands, including a 550W Ka-band solid-state power amplifier,
               supported by a £1.2 million UK Space Agency NSIP award received post period
               end.
 ·             Next-generation GaN amplifier systems remain on track for launch in calendar
               year 2026, including expansion into V-band, and expected to be a key driver of
               growth over the next three to five years.

 

Operational scale and investment to support future growth

 

 ·             Self-funded relocation to a larger headquarters and manufacturing facility
               completed during H1 FY2026, providing materially increased production capacity
               and capability to support demand.
 ·             Investment in the technology and product roadmap continues at pace, reflecting
               the Board's confidence in medium- and long-term opportunities.
 ·             Enhanced programme management and organisational capability to support a
               growing number of concurrent major customer programmes.

 

Outlook

 

 ·             Filtronic has entered the second half of FY2026 with a record order book,
               increasing customer diversification and strong engagement across its core
               markets.
 ·             Growing visibility and quality of revenues, with approximately 90% of FY2026
               revenues covered by contracted orders, providing strong visibility into H2 and
               beyond.
 ·             After a good first half, with strong momentum in the business, the Board
               remains confident in meeting current market expectations for revenues and
               EBITDA for FY2026.

 

Nat Edington, Chief Executive Officer, commented: "The first half of the year
demonstrated the strength of Filtronic's positioning in markets where
performance, reliability and security are mission critical. Demand across our
space, aerospace and defence markets remains robust, and our focus on
high-frequency RF technologies continues to differentiate us with customers
operating in the most demanding environments.

 

With a record order book, increasing customer diversification and the business
now operating at greater scale, we have entered the second half confident of
continuing our planned growth."

 

(1) As at 2 February 2026, the Board understands that market expectations for
FY2026, based on published analyst forecasts, are for revenue of £55.5m,
within a range of £54m to £56.9m and EBITDA of £10.9m, within a range of
£10.1m to £12.0m.

 

Enquiries

 

 Filtronic plc                                                   www.filtronic.com
 Nat Edington, CEO                                               01740 618800 or
 Michael Tyerman, CFO                                            investor.relations@filtronic.com

 Cavendish Capital Markets Limited (Nomad and Corporate Broker)  020 7220 0500
 Jonny Franklin-Adams/Isaac Hooper/Callum Davidson (Corporate Finance)
 Sunila de Silva (Corporate Broking)

 Berenberg (Joint Broker)              020 7220 0500
 Tom Ballard, Mark Whitmore, Harry Nicholas,

 Brooke Harris-Lowing
 Alma Strategic Communications                                   020 3405 0205 or filtronic@almastrategic.com
 Caroline Forde, Hannah Campbell, Rose Docherty

Alma Strategic Communications

020 3405 0205 or filtronic@almastrategic.com

Caroline Forde, Hannah Campbell, Rose Docherty

 

Notes:

 

This announcement contains inside information for the purposes of Article 7 of
Regulation (EU) No 596/2014.

Forward-looking statements

 

Certain statements in this half-yearly financial report are forward-looking.
Where the half-yearly financial report includes forward-looking statements,
these are made by the directors in good faith based on the information
available to them at the time of their approval of this report. Such
statements are based on current expectations and are subject to a number of
risks and uncertainties, including both economic and business risk factors
that could cause actual events or results to differ materially from any
expected future events or results referred to in these forward-looking
statements. Unless otherwise required by applicable law, regulation or
accounting standard, the Group undertakes no obligation to update any
forward-looking statements whether as a result of new information, future
events or otherwise.

 

 

Chief Executive's review

H1 FY2026 has been one of strong strategic execution for Filtronic. We have
continued to build on our technological leadership and long-standing customer
relationships, while investing to support the next phase of growth. The
momentum achieved during the half reflects both the scale of the opportunity
in our core markets and the progress we are making in building a business
capable of supporting sustained diversified growth.

 

Market dynamics

We operate in markets where performance, reliability and security are
mission-critical, and where demand remains robust. Our core markets of space
and defence continue to be supported by sustained satellite deployment
activity, increased defence expenditure and growing requirements for secure,
high-frequency communications. Customer programmes are increasingly focused on
higher spectrum solutions and advanced technologies such as gallium nitride
("GaN"), areas where Filtronic has established a market leading technical
capability. As a result, we continue to see active engagement across both new
and existing customers, reinforcing our positioning within these strategically
important markets.

 

Financial performance

In the first half of the year, as expected, revenue was broadly in line with
the prior period at £25.3m (H1 FY2025: £25.6m). As previously communicated,
deliberate and targeted investment in the business, to achieve sustainable
long-term revenue growth in high-growth markets, meant profits were lower in
the period than the same period last year with adjusted EBITDA of £5.1m (H1
2025: £8.7m) and an operating profit of £2.6m (H1 2025: £6.8m).

 

As highlighted in previous announcements, the weaker USD had an impact on
revenues in the period, given the Group's significant exposure to North
America. At the same time, the benefits of last year's strategic investments
are starting to be realised, including the expansion of our engineering teams,
the opening of our new facility, and the associated increase in production
capacity to support future growth. While these initiatives have increased
costs in the short term, they establish a strong foundation for sustainable
growth and are critical to strengthening the business for the years ahead.

 

We ended the Period in a strong financial position, with £10.5m of cash in
the bank (31 May 2025: £14.5m), having self-financed the capital project to
relocate to the larger headquarters and manufacturing site at Sedgefield, and
£8.2m in net cash when excluding right of use property leases (31 May 2025:
£5.1m).

 

Strategic progress

The Period was characterised by significant contract momentum and further
deepening of key customer relationships. We secured our two largest contract
awards with SpaceX, which strengthened our strategic relationship, of which
the second contract will start to be delivered in FY2027. On top of this, the
second award worth £47.3m, represents the first deployment of our next
generation, proprietary GaN E-band product. These wins demonstrate not only
confidence in our products, but also in our ability to deliver consistently,
at scale and to demanding specifications.

 

Alongside this, we continued to make strong progress in diversifying our
customer base, as demonstrated by a €7.0m (£5.8m) multi-year contract with
a leading European aerospace manufacturer. This contract is to supply RF
assemblies for integration into a major Low Earth Orbit satellite
constellation programme. In addition, we secured a £13.4m contract with a
leading European defence prime for the supply of high-performance active
components for the next phase of a long-standing electronic sensor programme.
Post-period end, we also secured an Authorisation to Proceed, for an expected
£11.0m contract, for a follow-on contract that gives order cover for a
further two-years with the same European defence prime.

 

Engagement with major primes, within space and defence, and government
organisations is increasing, supported by our sovereign accreditations,
manufacturing capabilities and proven track record in high-reliability RF
systems. This diversification is an important strategic priority, reducing
customer concentration over time while also expanding our addressable market.

 

We moved into our new headquarters in Sedgefield in November and will be
periodically migrating our manufacturing lines over the next few months as
customer programmes allow for transfer. The official opening of the building
will take place on 26 February 2026 as we celebrate our new state-of-the-art
facility enabling us to scale and futureproof the business operations for the
next phase of growth.

 

Innovation

Innovation is central to Filtronic's long-term growth strategy. As demand for
high-speed data continues to accelerate, communications systems are
increasingly moving into higher RF bands to enhance performance and alleviate
congestion at lower frequencies.

 

The V-band and W-band regions of the RF spectrum offer substantial potential
for next-generation, high-capacity wireless communications. V-band, in
particular, provides extensive bandwidth and is expected to be widely adopted
by satellite communication companies.

 

Filtronic is at the forefront of developing the critical enabling technologies
needed to unlock the full potential of these higher-frequency bands. Our Cerus
range of solid-state power amplifiers ("SSPAs") delivers class-leading power
performance across V-band, E-band and W-band frequencies. As bandwidth and
data demands continue to grow, these SSPAs are well positioned to support a
wide range of high-performance wireless and space applications.

 

This technology leadership is underpinned by strong execution against our
product roadmap. The successful development and initial deployment of our GaN
E-band product, represent a step change in performance and reinforces the
progress being made across our innovation programme. Further product launches
are planned for calendar year 2026, targeting emerging opportunities in space
ground systems. Our family of very high-power V-band amplifiers being released
in FY2026 will open up opportunities in medium earth orbit ("MEO") and
geostationary ("GEO") for the business for the first time. In addition, the
recent award of £1.2 million in funding from the UK Space Agency's National
Space Innovation Programme, supporting the development of a 550W Ka-band
solid-state power amplifier, further reinforces our intent to capitalise on
the significant opportunity emerging within the global space ecosystem.

 

People and operations

The progress delivered by our teams across the business in the first half of
the year has been instrumental in strengthening both our execution capability
and commercial momentum. Investment in our commercial teams is enabling
earlier and more effective engagement across programme lifecycles, enhancing
alignment with major primes and government customers, whilst also accelerating
the expansion of our opportunity pipeline.

 

This commercial momentum is matched by the continued scaling of our
engineering capability. The successful expansion of our Cambridge operation in
FY2025 now supports multiple concurrent development programmes, while the
self-funded relocation to a larger headquarters and manufacturing facility in
Sedgefield provides materially increased production capacity and capability.

 

Together, these advances reflect a more integrated, higher-value organisation,
better positioned to capture complex, global opportunities. They also support
our strategic progression up the value chain, expanding our expertise beyond
RF into digital, software, and system-level solutions.

 

Outlook

The first half of the year has demonstrated that the investments made in both
capacity, capability and technology, are delivering tangible commercial
successes. With a record order book, including new and diverse customer
contract wins, we have entered H2 in a strong position and are confident of
meeting market expectations for the full year.

 

Over the longer term, customers are expressing a growing need for
high-frequency, secure, and resilient communications infrastructure across
many platforms which provide the Group with supportive structural growth
drivers across its key markets. With our expanded manufacturing capacity now
fully operational, we believe we have exciting products and capabilities to
match this growing need.

 

Nat Edington

Chief Executive Officer, 3 February 2026

Condensed Consolidated Interim Income Statement

For the period ended 30 November 2025

 

 

                                                                                         6 months         6 months                                    Year
                                                                                         Ended            Ended                                       Ended
                                                                                         30 November      30 November                                 31 May
                                                                                         2025             2024                                        2025
                                                                                         (Unaudited)      (Unaudited)                                 (Audited)
 Continuing operations                                                  Note             £000             £000                                        £000

 Revenue                                                                5                25,253           25,595                                      56,318
                                                                                         ======           ======                                      ======

 Adjusted EBITDA¹                                                                        5,059            8,712                                       17,011
 Depreciation of property, plant and equipment and right of use assets                   (807)            (607)                                       (1,315)
 Amortisation of intangible assets                                                       (339)            (258)                                       (537)
 Amortisation of contract assets                                                         (889)            (901)                                       (1,303)
 Share-based payments                                                                    (408)            (185)                                       (414)
                                                                                         ----------       ----------                                  ----------
 Operating profit                                                       6                2,616            6,761                                       13,442
 Finance costs                                                                           (168)            (127)                                       (268)
 Finance income                                                                          165              101                                              213
                                                                                         ----------       ----------                                  ----------
 Profit before taxation                                                                  2,613            6,735                                       13,387
 Taxation                                                                                29                                   (7)                     662
                                                                                         ----------       ----------                                  ----------
 Profit for the period                                                                   2,642            6,728                                       14,049
                                                                                         ======           ======                                      ======

 Basic and diluted earnings per share (pence)

 Basic earnings per share                                               7                1.20p            3.08p                                       6.42p
 Diluted earnings per share                                             7                1.14p            3.04p                                       6.05p
                                                                                           ======         ======                                      ======

1              Adjusted EBITDA is defined as profit before
interest, taxation, depreciation, amortization, share-based payments and
exceptional items which is a non-GAAP metric used by management and is not an
IFRS disclosure.

 

Condensed Consolidated Interim Statement of Comprehensive Income

For the period ended 30 November 2025

 

                                                                         6 months     6 months     Year
                                                                         Ended        Ended        Ended
                                                                         30 November  30 November  31 May
                                                                         2025         2024         2025
                                                                         (Unaudited)  (Unaudited)  (Audited)
                                                                         £000         £000         £000

 Profit for the period                                                   2,642        6,728        14,049
                                                                         ----------   ----------   ----------
 Items that are or may be subsequently reclassified to profit and loss:
 Currency translation arising on consolidation                           (78)         (15)         154
                                                                         ----------   ----------   ----------
 Total comprehensive income for the period                               2,564        6,713        14,203
                                                                         ======       ======       ======

 

The total comprehensive income for the period is attributable to the equity
shareholders of the parent company Filtronic plc.

 

Condensed Consolidated Interim Statement of Financial Position

At 30 November 2025

 

                                       Note  30 November  30 November  31 May
                                             2025         2024         2025
                                             (Unaudited)  (Unaudited)  (Audited)
                                             £000         £000         £000
 Non-current assets
 Goodwill and other intangible assets        4,506        2,604        3,507
 Right of use assets                         4,530        3,774        4,546
 Property, plant and equipment               9,854        2,061        4,508
 Contract assets                       8     651          1,302        1,302
 Deferred tax                                1,758        1,046        1,754
                                             ----------   ----------   ----------
                                             21,299       10,787       15,617
                                             ----------   ----------   ----------
 Current assets
 Inventories                                 5,429        4,202        4,010
 Trade and other receivables                 14,517       15,070       12,169
 Contract assets                       8     3,266        401          3,504
 Cash and cash equivalents                   10,506       7,204        14,494
                                             ----------   ----------   ----------
                                             33,718       26,877       34,177
                                             ----------   ----------   ----------

                                             ----------   ----------   ----------
 Total assets                                55,017       37,664       49,794
                                             ----------   ----------   ----------
 Current liabilities
 Trade and other payables                    7,228        8,224        9,119
 Provisions                                  535          493          516

 Deferred Income                       9     4,751        1,426        851
 Lease liabilities                           1,164        731          1,112
                                             ----------   ----------   ----------
                                             13,678       10,874       11,598
                                             ----------   ----------   ----------
 Long term liabilities
 Deferred income                       9     220          116          247
 Lease liabilities                           2,510        2,214        2,573
                                             ----------   ----------   ----------
                                             2,730        2,330        2,820
                                             ----------   ----------   ----------

                                             ----------   ----------   ----------
 Total liabilities                           16,408       13,204       14,418
                                             ----------   ----------   ----------

                                             ----------   ----------   ----------
 Net assets                                  38,609       24,460       35,376
                                             ======       ======       ======
 Equity
 Share capital                         10    10,801       10,800       10,800
 Share premium                         11    11,458       11,352       11,354
 Share warrant reserve                 12    6,109        2,605        6,109
 Translation reserve                         (598)        (537)        (676)
 Retained earnings                           10,839       240          7,789
                                             ----------   ----------   ----------
 Total equity                                38,609       24,460       35,376
                                             ======       ======       ======

The total equity is attributable to the equity shareholders of the parent
company Filtronic plc.

Company number 2891064

 

Condensed Consolidated Interim Statement of Changes in Equity

For the period ended 30 November 2025

 

                                                         Share capital  Share premium  Share warrant reserve  Translation reserve  Retained earnings  Total equity
                                                         £000           £000           £000                   £000                 £000               £000

 Balance at 30 November 2024                             10,800         11,352         2,605                  (537)                240                24,460
 Profit for the period                                   -              -              -                      -                    7,321              7,321
 New shares issued (net of issue costs)                  -              2              -                      -                    -                  2
 Share warrants                                          -              -              3,504                                                          3,504
 Currency translation movement arising on consolidation  -              -              -                      (139)                -                  (139)
 Share-based payments                                    -              -              -                      -                    228                228
                                                         ----------     ----------     ----------             ----------           ----------         ----------
 Balance at 31 May 2025                                  10,800         11,354         6,109                  (676)                7,789              35,376
 Profit for the period                                   -              -              -                      -                    2,642              2,642
 New shares issued (net of issue costs)                  1              104            -                      -                    -                  105
 Currency translation movement arising on consolidation  -              -              -                      78                   -                  78
 Share-based payments                                    -              -              -                      -                    408                408
                                                         ----------     ----------     ----------             ----------           ----------         ----------
 Balance at 30 November 2025                             10,801         11,458         6,109                  (598)                10,839             38,609
                                                         ======         ======         ======                 ======               ======             ======

 

Condensed Consolidated Interim Cash Flow Statement

For the period ended 30 November 2025

                                                        6 months     6 months     Year
                                                        Ended        Ended        Ended
                                                        30 November  30 November  31 May
                                                        2025         2024         2025
                                                        (Unaudited)  (Unaudited)  (Audited)
                                                        £000         £000         £000
 Operating profit                                       2,616        6,761         13,442
 Tax received/(paid)                                    28           (7)          (49)
 Share-based payments                                   408          186          414
 Depreciation                                           807          607          1,315
 Amortisation of contract assets                        889          901          1,303
 Amortisation of intangible assets                      339          258          537
 Movement in inventories                                (1,406)      (926)        (797)
 Movement in trade and other receivables                (2,307)      (8,534)      (5,671)
 Movement in trade and other payables                   (1,902)      2,820        3,762
 Movement in provisions                                 19           -            24
 Change in deferred income                              3,873        8            (437)
                                                        ----------   ----------   ----------
 Net cash generated from operating activities           3,364        2,074        13,843
                                                        ----------   ----------   ----------
 Cash flows from investing activities
 Capitalisation of development costs                    (1,295)      (486)        (1,496)
 Acquisition of intangible assets                       (43)         (103)        (277)
 Acquisition of plant and equipment                     (5,574)      (1,535)      (3,835)
 Acquisition of right of use assets                     (553)        -            (177)
 Interest received                                      165          101          163
                                                        ----------   ----------   ----------
 Net cash used in investing activities                  (7,300)      (2,023)      (5,622)
                                                        ----------   ----------   ----------
 Cash flows from financing activities
 Interest paid                                          (168)        (127)        (268)
 Exercise of employee share options                     105          141          143
 Repayment of principal element of lease liabilities    (507)        (437)        (915)
 Receipt of interest-bearing borrowings                 495          364          137
                                                        ----------   ----------   ----------
 Net cash generated used in financing activities        (75)         (59)         (903)
                                                        ----------   ----------   ----------
 Movement in cash and cash equivalents                  (4,011)      (8)          7,318
 Currency exchange movements                            23           (3)          (39)
 Opening cash and cash equivalents                      14,494       7,215        7,215
                                                        ----------   ----------   ----------
 Closing cash and cash equivalents                      10,506       7,204        14,494
                                                        ======       ======       ======

 

Notes to the Condensed Financial Statements

 

1    Company information

 

      Filtronic plc is a company registered and domiciled in the United
Kingdom and is listed on the AIM market of the London Stock Exchange. The
Company's registered number is 2891064. The address of the Company's
registered office is Filtronic plc, Plexus 1, NETPark, Thomas Wright Way,
Sedgefield, County Durham, TS21 3FD.

 

   Copies of the Company's Annual Report and interim financial report are
available from the Company's registered office or the Company's website at
www.filtronic.com.

 

2    Basis of preparation

 

      Whilst the financial information included in this preliminary
statement has been prepared on the basis of the requirements of IFRSs in
issue, this statement does not itself contain sufficient information to comply
with IFRS.

 

      These financial results for the six months ended 30 November 2025
do not comprise statutory accounts within the meaning of Section 434 of the
Companies Act 2006. The interim report should be read in conjunction with the
Annual Report 2025, which includes annual financial statements for the year
ended 31 May 2025. Those accounts have been reported on by the Company's
auditor and delivered to the registrar of companies. The report of the auditor
was (i) unqualified (ii) did not include a reference to any matters to which
the auditor drew attention by way of emphasis without qualifying their report,
and (iii) did not contain a statement under section 498 (2) or (3) of the
Companies Act 2006.

 

     The condensed consolidated financial statements for the six months
ended 30 November 2025 consolidate the financial statements of the Company and
all of its subsidiaries (together referred to as the "Group"). Transactions
between Group companies, which are related parties, have been eliminated upon
consolidation and therefore do not require disclosure.

 

    The condensed consolidated financial statements for the six months ended
30 November 2025 and comparative period have not been audited. The interim
financial report for the six months ended 30 November 2025 was approved by the
Board on 2 February 2026.

 

3    Going Concern

 

In accordance with corporate governance requirements the directors have
undertaken a review of forecasts and the Group's cash requirements to consider
whether it is appropriate that the Group continues to adopt the going concern
assumption.

 

The directors have reviewed the projected cash flow and other relevant
information, including a 'severe but plausible' scenario and have a reasonable
expectation that the Group has adequate resources to continue in operational
existence and therefore it remains appropriate to adopt the going concern
basis in preparing the interim financial report for the six months ended 30
November 2025.

 

4      Accounting estimates and judgements

 

    The preparation of the financial statements requires the use of
accounting estimates and judgements that affect the application of accounting
policies and reported amounts of assets and liabilities, income and expenses.
The accounting estimates and judgements are continually evaluated and are
based on historical experience and other factors, including expectations of
the future that are believed to be reasonable under the circumstances. Actual
results may differ from the expected results. Revisions to accounting
estimates are recognised in the period in which the estimate is revised if the
revision affects only that period, or in the period of the revision and future
periods if the revision affects both current and future periods. The
accounting estimates and judgements that have a significant effect on the
financial statements are considered in the Filtronic plc Annual Report for the
year ended 31 May 2025 which can be found on the Filtronic website. Unless
stated below there is no material change to those judgements from the Annual
Report in the basis of calculation.

 

5   Segmental Analysis

      Operating Segments

      IFRS 8 requires consideration of the identity of the Chief
Operating Decision Maker ('CODM') within the Group. In line with the Group's
internal reporting framework and management structure, the key strategic and
operating decisions are made by the Board, who reviews internal monthly
management reports, budget and forecast information as part of this.
Accordingly, the Board is deemed to be the CODM.

      The CODM has identified one operating segment within the Group as
defined under IFRS 8. In turn, this is the only reportable segment of the
Group as the entities in the Group have similar products and services,
production processes and economic characteristics. Therefore, there is no
allocation of operating expenses, profit measures or assets and liabilities to
specific commercial markets.

Accordingly, the CODM assesses the performance of the operating segment on
financial information which is measured and presented in a manner consistent
with those in the financial statements by reference to Group results against
budget.

The Group profit measures are adjusted operating profit and adjusted EBITDA,
both disclosed on the face of the consolidated income statement. No
differences exist between the basis of preparation of the performance measures
used by management and the figures in the Group financial statements.

5   Segmental Analysis (continued)

Revenue by Destination

 

The revenue presented is based on the geographic location of customers
receiving the product/service from the continuing operations.

 

                           6 months     6 months     Year
                           Ended        Ended        Ended
                           30 November  30 November  31 May
                           2025         2024         2025
                           £000         £000         £000
     Revenue
     United Kingdom        1,551        1,559        3,946
     Europe                984          508          1,205
     Americas              22,656       23,446       51,163
     Rest of the world     62           82           4
                           ----------   ----------   ----------
                           25,253       25,595       56,318
                           ======       ======       ======

 

Revenue from sales

 

The revenue presented is based on the Group deriving revenue from product
sales and those received from Non-Recurring Engineering ("NRE") at a point in
time when the performance obligation is satisfied.

 

                                         6 months     6 months     Year
                                         Ended        Ended        Ended
                                         30 November  30 November  31 May
                                         2025         2024         2025
                                                      £000         £000
     Revenue
     Sales of product                    24,543       25,565       54,603
     NRE - point in time                 1,599        931          3,018
     Amortisation of contract assets     (889)        (901)        (1,303)
                                         ----------   ----------   ----------
                                         25,253       25,595       56,318
                                         ======       ======       ======

 

6   Operating profit

 

                                                                        6 months     6 months     Year
                                                                        Ended        Ended        Ended
                                                                        30 November  30 November  31 May
                                                                        2025         2024         2025
                                                                        £000         £000         £000

      Revenue                                                           25,253       25,595       56,318
                                                                        ----------   ----------   ----------
 Material cost of goods sold                                            11,005       9,738        21,855

      Wages and salaries                                                5,440        4,187        10,316
 Social security costs                                                  702          469          1,019
 Pension costs                                                          448          269          560
 Bonus                                                                  358          540          1,354
 Temporary employees                                                    467          418          900
 Share-based payments                                                   404          186          414
                                                                        ----------   ----------   ----------
 Employee costs                                                         7,819        6,069        14,563
                                                                        ----------   ----------   ----------
 Amortisation of intangible assets                                      339          258          537
 Depreciation of property, plant and equipment and right of use assets  836          607          1,315
                                                                        ----------   ----------   ----------
 Depreciation and amortisation                                          1,175        865          1,852
                                                                        ----------   ----------   ----------
 Other operating income                                                 (239)        (34)         (446)
 Other expenses                                                         2,877        2,196        5,052
                                                                        ----------   ----------   ----------
 Total operating costs                                                  11,632       9,096        21,021
                                                                        ======       ======       ======
 Operating profit                                                       2,616        6,761        13,442
                                                                        ======       ======       ======

 

Development costs of £1,295,000 were capitalised in H1 2026 (HY2025:
£486,000).

 

Other operating income relates to grants received for plant and machinery and
R&D innovation whilst R&D tax credits under the new merged scheme are
also recognised in operating profit.

 

7   Basic and diluted earnings per share

 

                                                                                        6 months     6 months     Year
                                                                                        Ended        Ended        Ended
                                                                                        30 November  30 November  31 May
                                                                                        2025         2024         2025
                                                                                                     £000         £000

       Profit for the period                                                            2,642        6,728        14,049
                                                                                        ======       ======       ======

                                                                                        '000         '000         '000
       Basic weighted average number of shares                                          219,653      218,771      218,854
 Dilution effect of share options                                                       12,503       2,663        13,389
                                                                                        -----------  -----------  -----------
       Diluted weighted average number of shares                                        232,156      221,434      232,243
                                                                                        =======      =======      =======

 Basic earnings per share (pence)                                                       1.20p        3.08p        6.42p

       Diluted earnings per share (pence)                                               1.14p        3.04p        6.05p
                                                                                        ======       ======       ======

 

8    Contract assets

 

 

Contract assets relate to the share warrants issued to Space X.

 

                                   6 months     6 months     Year
                                   Ended        Ended        Ended
                                   30 November  30 November  31 May
                                   2025         2024         2025
                                   £000         £000         £000

 Opening contract assets           4,806        2,605        2,605
 New contract assets generated     -            -            3,504
 Amortised to revenue              (889)        (901)        (1,303)
                                   ----------   ---------    ---------
                                   3,917        1,703        4,806
                                   ======       ======       ======

 

                                             6 months     6 months     Year
                                             Ended        Ended        Ended
                                             30 November  30 November  31 May
                                             2025         2024         2025
                                             £000         £000         £000

 Contract assets due in one to five years    3,266        401          3,504
                                             ----------   ---------    ---------
 Current contract assets                     3,266        401          3,504
                                             ======       ======       ======

 Contract assets due in one to five years    651          1,302        1,302
                                             ----------   ---------    ---------
 Non-current contract assets                 651          1,302        1,302
                                             ======       ======       ======

 

9 Deferred income

 

                                               6 months         6 months     Year
                                               Ended            Ended        Ended
                                               30 November      30 November  31 May
                                               2025             2024         2025
                                               £000             £000         £000

 Contract liabilities                          4,699            1,484        799
 Capital grant                                 52               29           52
                                               -----------      -----------  -----------
 Total current deferred income                 4,751            1,513        851
                                               -----------      -----------  -----------
       Contract liabilities                    -                -            -
 Capital grant                                 220              116          247
                                               -----------      -----------  -----------
       Total non-current deferred income       220              116          247
                                               -----------      -----------  -----------
 Total deferred income                         4,971            1,629        1,098
                                                       =======  =======      =======

 

Contract liabilities are invoices raised in advance of NRE work completed for
customers that will be recognised as income once the performance obligation of
the contract has been met. The majority of NRE contracts are invoiced with a
proportion of the contract value upfront which is recognised as revenue, over
time, across the life of contract at each milestone based on the percentage of
the overall contract value achieved at that performance obligation.

 

 

10   Share Capital

 

                                           Deferred shares of 10p each     Ordinary shares of 0.1p each
                                           Number '000                     Number '000    £000

 At 30 November 2024                       106,877                         218,982        10,800
 Exercise of employee share options        -                               20             -
                                           ------------                    -------------  -------------
 At 31 May 2025                            106,877                         219,002        10,800
 Exercise of employee share options        -                               940            1
                                           ------------                    ------------   -------------
 At 30 November 2025                       106,877                         219,942        10,801
                                           ========                        ========       ========

All shares are allotted, called up and fully paid. Holders of the ordinary
shares and entitled to retrieve dividends when declared and are entitled to
one vote per share at meetings of the company.

 

Holders of the ordinary shares are entitled to receive dividends when declared
and are entitled to one vote per share at meetings of the Company.

11   Share Premium

 

                                          £000

 At 30 November 2024                     11,352
 Exercise of employee share options      2
                                         -----------
 At 31 May 2025                          11,354
 Exercise of employee share options      104
                                         -----------
 At 30 November 2025                     11,458
                                         =======

 

12     Share Warrant Reserve

 

Tranche 1 and 2

On 24 April 2024, the Group entered into a share warrant arrangement with
SpaceX in conjunction with a

commercial agreement and strategic partnership. This related to the supply of
E-band Solid State Power Amplifiers ("SSPAs") and new technology being
developed for SpaceX for use in their Starlink constellation.

 

The warrant agreement grants SpaceX the right to acquire up to 21,712,109
shares of the Company (equivalent to 10% of the Company's total share capital
at the inception of the warrant agreement). The exercise price of vested
warrants is 33.0p per share, based on the closing mid-market price at 23 April
2024, which is the date prior to signing the warrant agreement. The directors
have assessed the warrants and made a judgement that the warrants should be
treated as equity instruments as defined by IAS 32. This is because the
warrants have a fixed consideration at 33.0p per share for a fixed number of
units to exercise.

 

The warrants have been recognised in the financial statements based on the
value at the date of signing of

the agreement. An initial entry has been made in contract assets measured at
fair value, but not subsequently remeasured, with the corresponding entry to
equity.

 

The initial fair value of the warrants at inception was £2,605,453, based on
a fair value per warrant of £0.11 and the total number of warrants expected
to vest over the 5-year vesting period. The directors have judged all of the
warrants will vest, otherwise SpaceX and Filtronic would not have entered into
the agreement. The warrants represent non-cash consideration payable to a
customer under IFRS 15. Therefore, the contract asset, which effectively
represents a deferred volume rebate, is amortised to revenue based on when the
units are supplied to SpaceX.

 

The fair value of the warrants was determined using the Black-Scholes Model
valuation method using a number of variables that require judgement including
share price volatility, discount to the bid price, the risk-free rate and the
expected life of the warrants. There are a number of variables that require
judgement within this model including the risk-free rate, share price
volatility, the vesting period and a bid price

discount.

 

Tranche 3

On 19 March 2025, the Company entered into a second warrant arrangement with
SpaceX expanding the

Original strategic partnership entered into on 23 April 2024 to secure an
increased allocation of business for the Group. The vesting of these warrants
is dependent on certain performance conditions relating to the procurement of
E-band SSPAs to support the Starlink constellation.

 

 

12     Share Warrant Reserve (continued)

 

 

The warrant agreement grants SpaceX the right to acquire up to 10,949,079 at
92.8p per share. The accounting treatment of the warrants has been judged by
management and has been determined to be treated the same as tranche 1 and 2.
An initial entry has been made in contract assets measured at fair value, but
not subsequently remeasured, with the corresponding entry to equity.

 

The initial fair value of the warrants at inception was £3,504,000, based on
a fair value per warrant of £0.93 and the total number of warrants expected
to vest over the 5-year vesting period. The directors have judged all of the
warrants will vest, otherwise SpaceX and Filtronic would not have entered into
the agreement. The warrants represent non-cash consideration payable to a
customer under IFRS 15. Therefore, the contract asset, which effectively
represents a deferred volume rebate, is amortised to revenue based on when the
units are supplied to SpaceX.

 

The fair value of the warrants was determined using the Black-Scholes Model
valuation method using a number of variables that require judgement including
share price volatility, discount to the bid price, the risk-free rate and the
expected life of the warrants. There are a number of variables that require
judgement within this model including the risk-free rate, share price
volatility, the vesting period and a bid price discount.

 

 

13   Analysis of net cash

 

                                                          1 June 2025  Cash Flow  Other movements  30 Nov 2025
                                                          £000         £000       £000             £000

 Cash and cash equivalents                                14,494       (4,011)    23               10,506
 Lease liability - plant and equipment                    (2,180)      457        (583)            (2,306)
                                                          ---------    ---------  ---------        ---------
 Net cash when including all debt except property leases  12,314       (3,554)    (560)            8,200
 Lease liability - property lease                         (1,505)      202        (62)             (1,365)
                                                          ---------    ---------  ---------        ---------
 Net cash                                                 10,809       (3,352)    (622)            6,835
                                                          ======       ======     ======           ======

 

Cash at bank earns interest at floating rates based on daily bank deposit
rates.

The Group entered into a financing arrangement in November 2024 with Santander
UK plc for a committed £5.0m Revolving Credit Facility ("RCF") for three
years. In December 2025, the Group extended this arrangement for a further
three years and increased the facility to £10.0m.

There were no drawings on the RCF facility at 30 November 2025 (31 May 2025:
undrawn).

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  IR UPURUPUPQGRP



            Copyright 2019 Regulatory News Service, all rights reserved

Recent news on Filtronic

See all news